Researchers Explore Possible Connection Between a Widely Used Drug and Dementia Risk
Emerging research is shining a light on concerning links between commonly prescribed medications and an increased risk of dementia.
Scientists are particularly investigating anticholinergic drugs, a broad class used to treat conditions such as allergies, overactive bladder, Parkinson’s disease, depression, and insomnia.
What Do the Studies Show?
- A large UK-based analysis found that using anticholinergics is associated with a 6% to 49% increase in dementia risk, depending on the dosage and duration of use. The highest risk was tied to prolonged, high-dose exposure.
- A distinct study noted that taking anticholinergics for three years or more was linked to a 54% higher dementia risk compared to those using them for a much shorter time.
- Another investigation showed that even low cumulative doses could elevate dementia risk—individuals taking these medications experienced a 1.4 to 2.0-fold increase, and in some cases, a staggering 227% increase in cognitive decline risk.
- A study involving older adults carrying Alzheimer’s biomarkers found that those on anticholinergics were 4 times more likely to develop mild cognitive impairment (MCI), compared to those not using these medications.
Together, these findings suggest a dose- and duration-dependent relationship, with chronic or high-dose use emerging as the greatest concern.
Why Might These Drugs Increase Dementia Risk?
Anticholinergic medications work by blocking acetylcholine, a neurotransmitter vital for memory and cognitive function. In people with preexisting Alzheimer’s risk factors, this “double hit”—already compromised brain chemistry plus drug-induced depletion—may accelerate cognitive decline.
What About Other Medications?
- Gabapentin, commonly prescribed for nerve pain and epilepsy, has also raised red flags. One study found that individuals with six or more prescriptions had a 29% greater risk of developing dementia, and were 85% more likely to develop MCI within 10 years.
- Benzodiazepines, used for anxiety and insomnia, are associated with cognitive impairment and, particularly in older adults, an elevated dementia risk.
- Antipsychotics, as another example, were linked to a 21-fold increase in dementia incidence when used by individuals under age 65.
What You Can Do
- If you’re on long-term anticholinergics—or any of the medications mentioned—it’s worth a conversation with your doctor. A personalized risk-benefit discussion might lead to safer alternatives or adjusted dosages.
- Be aware of the cumulative “anticholinergic burden” when combining multiple medications.
- In some cases, safely tapering off or switching medications may help reduce dementia risk without compromising treatment efficacy.
The Bottom Line
Research increasingly links anticholinergic drugs—and some other commonly prescribed medications—to heightened dementia risk, especially with extended or high-dose use. While these findings do not prove causation, they warrant caution and conversation—particularly for individuals with long-term prescriptions.
It’s increasingly clear: what’s good for treating one health issue may carry cognitive trade-offs down the line. A thoughtful, doctor-guided approach remains your best path forward.
